Exagen Inc. XGN Reportable Segment — Gross Profit
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:GrossProfit.
The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s reportable segment — gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Exagen Inc.'s reportable segment — gross profit?
- Exagen Inc. (XGN) reported reportable segment — gross profit of $10.21M in Q1 2026.
- How has Exagen Inc.'s reportable segment — gross profit changed year-over-year?
- Exagen Inc.'s reportable segment — gross profit increased by 11.9% year-over-year, from $9.12M to $10.21M.
- What is the long-term trend for Exagen Inc.'s reportable segment — gross profit?
- Over 2 years (2023 to 2025), Exagen Inc.'s reportable segment — gross profit has grown at a 14.8% compound annual growth rate (CAGR), from $29.46M to $38.8M.
- What does reportable segment — gross profit mean?
- Calculated as the segment's revenue minus its direct cost of revenue, representing the core profitability of the diagnostic testing business before operating expenses. This metric highlights the segment's pricing power and the efficiency of its diagnostic service delivery model.